Skip to main navigation
Skip to search
Skip to main content
UT MD Anderson Cancer Center Home
Help & FAQ
Link opens in a new tab
Search content at UT MD Anderson Cancer Center
Home
Profiles
Research units
Equipment
Research output
Activities
Prizes
The roles of copper transporters in cisplatin resistance
Macus Tien Kuo
, Helen H.W. Chen
, Im Sook Song
, Niramol Savaraj
, Toshihisa Ishikawa
Translational Molecular Pathology
Research output
:
Contribution to journal
›
Review article
›
peer-review
255
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The roles of copper transporters in cisplatin resistance'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cisplatin
100%
Cisplatin Resistance
100%
Platinum-based
100%
Copper Transporter
100%
Platinum Drugs
100%
Antitumor Agents
66%
ATP7B
66%
Mechanistic Aspects
66%
ATP7A
66%
Intracellular Accumulation
33%
Oxaliplatin
33%
Carboplatin
33%
Physiologic
33%
In Cancer
33%
Drug Development
33%
Drug Resistance
33%
Human Malignancies
33%
Efflux
33%
Cancer Chemotherapy
33%
Functional Aspects
33%
Drug Transporters
33%
Copper Homeostasis
33%
Enhanced Efficacy
33%
CTR1
33%
Transporter Activity
33%
Influx Transporters
33%
Drug Intake
33%
Copper Efflux
33%
HCtr1
33%
Efflux Transporters
33%
Copper Ion
33%
Pharmacology, Toxicology and Pharmaceutical Science
Cisplatin
100%
Platinum
100%
Anticarcinogen
33%
Effusion
33%
Oxaliplatin
16%
Carboplatin
16%
Drug Resistance
16%
Cancer Chemotherapy
16%
Copper Ion
16%
Neuroscience
Cisplatin
100%
Anticarcinogen
50%
Drug Resistance
25%
Carboplatin
25%
Oxaliplatin
25%
Chemotherapy
25%
Biochemistry, Genetics and Molecular Biology
Cisplatin
100%
ATP7A
50%
Homeostasis
25%
Drug Resistance
25%
Copper Ion
25%